National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs

To further advance NCCN’s mission to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives, NCCN is devoted to being the world's leader in defining and advancing high-quality, high-value cancer care globally.

The global influence and demand for the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) is ever increasing. Today, nearly half of all registered users of the NCCN Guidelines® on NCCN.org report that they lived outside the United States.  In order to increase the global access to high quality, high value cancer care, NCCN has developed the following strategic global initiatives.

Organizations who are interested in supporting NCCN Global programs are encouraged to contact Jorge Bacigalupo, Global Business Development Program Manager or download the complete NCCN 2018 Global Programming Prospectus.

NCCN Corporate Council: Global Membership – NCCN offers the opportunity for industry supporters to expand to a Global Corporate Council membership. Learn more

Translation of NCCN Content – NCCN offers the opportunity to support translation, maintenance of translations, and/or distribution of NCCN Content globally, including the NCCN Guidelines, the NCCN Guidelines for Patients®, and/or the NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™).  Currently, there are 66 translations available on NCCN.org. Learn more

Global Outreach and Guidelines Adaptations – NCCN works in collaboration with third party organizations across the globe to present the NCCN Guidelines and derivative products to international audiences of clinicians and other medical professionals. Demonstrating the continued global influence and demand for the NCCN Guidelines, NCCN faculty has traveled to Argentina, Brazil, China, Japan, Saudi Arabia, South Africa, South Korea, and the United Arab Emirates to discuss NCCN Guidelines. There are currently 16 regional NCCN Guidelines adaptions and consensus statements published on NCCN.org. Learn more

NCCN has presented the NCCN Guidelines and supporting data at interactive educational programs in:

NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework™) The NCCN Framework™ guides evidence-based adaptation to available clinical treatment resources. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are used widely around the world, including in a number of low and middle income countries (LMICs) where certain diagnostic tests and/or treatment approaches may be unavailable. The goal of the NCCN Framework™ is to define appropriate treatment pathways based on available resources—Basic, Core, Enhanced, and NCCN Guidelines®—and deliver a tool for health care providers to identify treatment options that will provide the best possible outcomes given specific resource constraints.

To learn more about NCCN Framework™, a new resource from NCCN, visit NCCN.org/framework.

NCCN Global Academy for Excellence & Leadership in Oncology™ – Pharmaceutical and biotechnology professionals are given the rare opportunity to view the global oncology space, its future and its current operational issues from the provider, payer, and patient advocate perspective. Participants will improve their working knowledge of key global business, policy, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in consideration of worldwide cancer care issues. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in the global oncology environment and how to apply this knowledge to create mutually successful working relationships. Learn more

Global Leadership Exchange – NCCN offers the opportunity to support a global leadership exchange which allows for International clinicians and/or administrators to observe and interact with NCCN faculty at an NCCN Member Institution and/or for NCCN faculty to travel abroad for a clinical exchange at an International facility. Learn more

NCCN International Day – NCCN holds NCCN International Day during the NCCN Annual Conference and is typically used as a forum to discuss regional modifications to the NCCN Guidelines. It also gives foreign physicians the opportunity to attend the NCCN Annual Conference to learn more about the NCCN Guidelines and the standard of care in the United States as well as to interact with U.S. physicians. Learn more

NCCN eBulletin: International Edition NCCN eBulletin: International Edition is an electronic newsletter delivered bi-monthly to all users of NCCN.org registered from outside the United States. The NCCN eBulletin: International Edition touches more than 190,000 foreign oncology professionals from approximately 200 countries who are eager to learn from NCCN. Learn more


View NCCN International Adaptations & Translations


View NCCN Trends™ International Surveys & Data


View NCCN eBulletin Articles on international initiatives


Educational Programs in the United States

If you are a foreign citizen interested to attend one of our domestic educational programs and require a visa application letter from NCCN to travel, please contact Jorge Bacigalupo, Global Business Development Specialist. Please allow three weeks for processing of your request.


Opportunities for Collaboration and Sponsorship

We welcome the opportunity to explore potential business collaborations with you.

If you have questions about NCCN international programs, please contact Jorge Bacigalupo, Global Business Development Specialist.

For general NCCN queries and domestic programs, please visit our main Contact Page.


Supporters of the NCCN Global Program

https://www.nccn.org/images/iar/takeda-118x59.jpg

Takeda Oncology supported the translation, verification, and subsequent maintenance/updates of several NCCN Guidelines into multiple languages, including Spanish, Portuguese, Chinese, South Korean, French, German, and Italian. In addition, Takeda Oncology is a long time member of the NCCN Global Corporate Council.